Life Saving Drugs Program resources – Paroxysmal nocturnal haemoglobinuria
A collection of resources for health professionals to help people with paroxysmal nocturnal haemoglobinuria access eculizumab (Soliris®) under the Life Saving Drugs Program.
This collection contains guidelines, forms and documents related to accessing eculizumab (Soliris®) under the Life Saving Drugs Program. Click to view the Soliris® product information on the Therapeutic Goods Administration website.
Medicines review documents
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.